Retinoic acid induces neuroblastoma cell death by inhibiting proteasomal degradation of retinoic acid receptor α

Cancer Research

Volumn 64, Issue 21, 2004, Pages 7910-7917

  Nagai, Jun Ichi ^a,b   Yazawa, Takuya ^b   Okudela, Koji ^c   Kigasawa, Hisato ^a   Kitamura, Hitoshi ^b   Osaka, Hitoshi ^a,d  

^a KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEASOME; PROTEASOME INHIBITOR; RETINOIC ACID; RETINOIC ACID RECEPTOR ALPHA; UBIQUITIN;

ARTICLE; CELL DEATH; CELL STRAIN; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

BENZOATES; CELL DIVISION; CELL LINE, TUMOR; CHROMANS; HUMANS; LEUPEPTINS; NEUROBLASTOMA; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TRETINOIN; UBIQUITIN;

EID: 7444247424     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-1178     Document Type: Article

References (25)

1. Bernstein ML, Leclerc JM, Bunin G, et al. A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol 1992;10:323-9.
2. Matthay KK, Villablanca JG, Seeger RC, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73.
3. Leid M, Kastner P, Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathway. Trends Biochem Sci 1992;17:427-33.
4. Mangelsdorf DJ, Evans RM. The RXR heterodimers and orphan receptors. Cell 1995;83:841-50.
5. Wuarin L, Chang B, Wada R, Sidell N. Retinoic acid up-regulates nuclear retinoic acid receptor-α expression in human neuroblastoma cells. Int J Cancer 1994;56:840-5.
6. Carpentier A, Balitrand N, Rochette-Egly C, Shroot B, Degos L, Chomienne C. Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers. Oncogene 1997;15:1805-13.
7. Cheung B, Hocker JE, Smith SA, Norris MD, Haber M, Marshall GM. Favorable prognostic significance of high-level retinoic acid receptor β expression in neuroblastoma mediated by effects on cell cycle regulation. Oncogene 1998;17:751-9.
8. Marshall GM, Cheung B, Stacey KP, et al. Increased retinoic acid receptor γ expression suppresses the malignant phenotype and alters the differentiation potential of human neuroblastoma cells. Oncogene 1995;11:485-91.
9. Helson L, Helson C. Human neuroblastoma cells and 13-cis-retinoic acid. J Neurooncol 1985;3:39-41.
10. Biedler JL, Helson L, Spengler BA. Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 1973;33:2643-52.
11. Nagai J, Ishida Y, Koga N, et al. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting residual neuroblastoma cells in peripheral blood using flow cytometry. J Pediatr Hematol Oncol 2000;22:20-6.
12. Apfel C, Bauer F, Crettaz M, et al. A retinoic acid receptor antagonist selectively counteracts retinoic acid effects. Proc Natl Acad Sci USA 1992;89:7129-33.
13. Jensen TJ, Loo MA, Find S, Williams DB, Goldberg AL, Riordan JR. Multiple proteolytic systems, including the proteasome, contribute to CFTR processing. Cell 1995;83:129-35.
14. Tamai M, Matsumoto K, Omura S, Koyama I, Ozawa Y, Hanada K. In vitro and in vivo inhibition of cysteine proteinases by EST, a new analog of E-64. J Pharmacobiodyn 1986;9:672-7.
15. Okudela K, Ito T, Mitsui H, et al. The role of p53 in bleomycin-induced DNA damage in the lung. A comparative study with the small intestine. Am J Pathol 1999;155:1341-51.
16. Zhu J, Gianni M, Kopf E, et al. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor α and oncogenic RARα fusion proteins. Proc Natl Acad Sci USA 1999;96:14807-12.
17. SKP2 and E2F-1 underlies the regulation of E2F-1 degradation. Nat Cell Biol 1999;1:14-9.
18. Sidell N. Retinoic acid-induced growth inhibition and morphologic differentiation of human neuroblastoma cells in vitro. J Natl Cancer Inst 1982;68:589-96.
19. Lopez-Boado YS, Klaus M, Dawson MI, Lopez-Otin C. Retinoic acid induced expression of apolipoprotein D and concomitant growth arrest in human breast cancer cells are mediated through a retinoic acid receptor RAR α-dependent signaling pathway. J Biol Chem 1996;271:32105-11.
20. Heyman RA, Mangelsdorf DJ, Dyck JA, et al. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell 1992;68:397-406.
21. Allenby G, Bocquel MT, Saunders M, et al. Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci USA 1993;90:30-4.
22. Borriello A, Pietra VD, Criscuolo M, et al. p27kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation. Oncogene 2000;19:51-60.
23. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997;387:299-303.
24. Weissman AM. Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2001;2:169-78.
25. Bastien J, Rochette-Egly C. Nuclear retinoid receptors and the transcription of retinoid-target genes. Gene 2004;328:1-16.